Literature DB >> 22812473

Treatment of intestinal pythiosis in a dog with a combination of marginal excision, chemotherapy, and immunotherapy.

Chad W Schmiedt1, Meri Stratton-Phelps, Bryan T Torres, Dennis Bell, Elizabeth W Uhl, Shawn Zimmerman, Jason Epstein, Karen K Cornell.   

Abstract

CASE DESCRIPTION: A 1.5-year-old mixed-breed dog was examined because of a 1-month history of anorexia, vomiting, diarrhea, and weight loss. CLINICAL
FINDINGS: The dog was very thin on physical examination (body condition score, 3/9). Results of all diagnostic tests were within reference limits except intestinal thickening and lymphadenopathy were identified on abdominal ultrasound examination. During exploratory laparotomy, thickening at the ileocecal-colic junction and within the transverse colon and mesenteric lymphadenopathy were identified, and the ileocecal-colic junction was resected. Histopathologic evaluation of the ileocecal-colic junction and full-thickness biopsy specimens from other sites as well as results of a serum ELISA were diagnostic for gastrointestinal Pythium insidiosum infection. TREATMENT AND OUTCOME: Pythiosis was initially treated medically with administration of itraconazole and terbinafine by mouth, but the colonic lesion was progressive with this regimen. Two months after diagnosis, a subtotal colectomy was performed; marginal excision (0.6 cm) was obtained at the aboral margin. The dog was treated with 3 doses of a pythiosis vaccine beginning approximately 2 weeks after surgery and was continued on itraconazole and terbinafine for 5 months. Parenteral and enteral nutrition as well as considerable general supportive care were required postoperatively. Six months after treatment, the dog had a normal serum ELISA titer. Two years after treatment, the dog had returned to preoperative weight and was clinically normal. CLINICAL RELEVANCE: This patient had an unusually positive therapeutic response to chronic, extensive, marginally excised gastrointestinal pythiosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22812473     DOI: 10.2460/javma.241.3.358

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  4 in total

Review 1.  Canine gastrointestinal pythiosis treatment by combined antifungal and immunotherapy and review of published studies.

Authors:  Daniela I B Pereira; Sônia A Botton; Maria I Azevedo; Marco A A Motta; Raulene R Lobo; Mauro P Soares; Anelise O S Fonseca; Francielli P K Jesus; Sydney H Alves; Janio M Santurio
Journal:  Mycopathologia       Date:  2013-08-07       Impact factor: 2.574

2.  A Leishmania murine model to evaluate the immunomodulatory properties of Pythium insidiosum proteins.

Authors:  Tatiana Maria Inêz-Ferreira; Leonel Mendoza; Raquel Vilela; Hélida Monteiro de Andrade; João Paulo Haddad; Fernanda Freire Campos Nunes; Isabela Moreira Gondim; Tânia Mara Pinto Dabés Guimarães; Vicente de Paulo Coelho Peixoto de Toledo
Journal:  Heliyon       Date:  2017-03-30

3.  Successful management of 3 dogs with colonic pythiosis using itraconzaole, terbinafine, and prednisone.

Authors:  Krystle L Reagan; Stanley L Marks; Patricia A Pesavento; Ann Della Maggiore; Bing Y Zhu; Amy M Grooters
Journal:  J Vet Intern Med       Date:  2019-04-19       Impact factor: 3.333

4.  Global Distribution and Clinical Features of Pythiosis in Humans and Animals.

Authors:  Hanna Yolanda; Theerapong Krajaejun
Journal:  J Fungi (Basel)       Date:  2022-02-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.